Phantom Neuro, a neurotechnology company that offers a muscle-machine interface for controlling prosthetic limbs and robotic exoskeletons, announced an oversubscribed $19 million Series A funding round, bringing its total raise to $28 million.
Ottobock led the round with participation from existing investors Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, and LionBird...
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes.
G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. ...
Research from Japan has demonstrated the use of eye-tracking technology in the early diagnosis of autism spectrum disorder.
Waseda University associate professor Mikimasa Omori set out to examine whether children with potential ASD would exhibit a preference for predictable movement – a behaviour indicative of the neurodevelopmental disorders – longer than typically developing children.
FINDINGS...
According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity.
While AI shows promise for enhancing how mammograms are interpreted, particularly in areas where resources are limited, the study's authors found warning signs regarding the...
Editors note: This article has been updated with content from Bliss.
Bliss Aesthetics, a company that connects patients to plastic surgeons, announced it secured $17.5 million in seed funding.
Shine Capital led the round, with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures and Cerca Partners.
WHAT IT DOES
Bliss Aesthetics matches patients to board-certified plastic...
Texas-based healthcare data analytics company MedeAnalytics announced it is collaborating with fellow healthcare data analytics firms Socially Determined and Mathematica.
The companies launched "Social Risk Insights, Measures and Outcomes," a program built on the MedeAnalytics Heath Fabric platform launched earlier this month.
Health Fabric, which is on the Snowflake AI Data Cloud, allows "...
Transcarent, a digital platform focused on the self-insured employer market, announced it finalized its merger with Accolade, a virtual healthcare and benefits navigation company, in a deal worth $621 million.
Transcarent announced that it was acquiring Accolade and taking it private in January. Accolade is now an indirect wholly owned subsidiary of Transcarent.
In a statement, the company said...
Samsung announced a joint research initiative with Stanford Medicine to enhance the Galaxy Watch's sleep apnea detection feature and create new AI-enabled innovations for proactive care.
The sleep apnea detection feature, which received FDA De Novo authorization last year, uses Samsung's Health Monitor app to detect signs of moderate-to-severe obstructive sleep apnea in adults 22 and older.
The...
Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.
Flatiron Health is an oncology-focused health technology company that offers a platform aimed at optimizing the clinical trial process, including selecting trial sites and identifying patients who are...
Willow, maker of wearable breast pumps, announced it acquired British femtech company Elvie to scale the companies' maternal health platforms.
San Francisco-based Willow offers in-bra breast pumps, pumping accessories and breast care. The company most recently received FDA 510(k) clearance for its breast pump, Willow Generation 3 Breast Pump, in October of last year.
Elvie offers its own line...
